Page 22 - Spectral Medical Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bioventus CEO Ken Reali Steps Down As CEO

(RTTNews) - Bioventus Inc. (BVS) announced Wednesday that Ken Reali has stepped down as Chief Executive Officer and as a member of the Board of Di.

Anthony bihlBioventus incSpectral medical incBoard of managers bioventusSonendo incKen realiChief executive officerClinical innovationsBaxano surgicalSpectral medical

SPECTRAL MEDICAL ANNOUNCES FOURTH QUARTER AND FISCAL 2022 RESULTS AND PROVIDES CORPORATE UPDATE

TORONTO - Spectral Medical Inc. , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the. | March 27, 2023

United statesChris setoJohn kellumContract research organizationSpectral medical incCompany endotoxin activity assayChief medical officerNorth americanWhile spectralEndotoxin activity assayBreakthrough device designationNews publishingSpectral medical inc stock exchangePress releaseOr edt ca8475771033

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTigris sitesthereJohn kellumAli mahdaviBaxter prismaxBlair mcinnisChris setoDavid waldman natalya rudmanCrescendo communicationsUniversity of south carolinaTimingthe companyDevice single audit programToronto stock exchangeDialco incCompany endotoxin activity assaySpinnaker capital markets inc

Insights on the Cardiac Biomarkers Global Market to 2027

Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) The "Cardiac Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's.

United statesJapan generalSouth koreaTransmyocardial revascularizationSiemens healthineersLife diagnostics incLsi medience corpSpectral medical incPerkinelmer incResponse biomedical corpMetanomics health gmbTrinity biotechCompany market share analysisBg medicine incMeridian life science incBeckman coulter

The Worldwide Cardiac Biomarkers Industry is Expected to Reach $23 8 Billion by 2027

/PRNewswire/ The "Cardiac Biomarkers: Technologies and Global Markets" report has been added to ResearchAndMarkets.com s offering. This report summarizes.

United statesJapan generalSouth koreaTransmyocardial revascularizationSiemens healthineersLaura woodLife diagnostics incLsi medience corpSpectral medical incPerkinelmer incResponse biomedical corpMetanomics health gmbTrinity biotechCompany market share analysisBg medicine incMeridian life science inc